Verona Pharma: Preparing a potentially novel COPD medicine for market

Update: 2023-07-24

Description

A much-anticipated new potential drug for COPD moved a step closer to the market after Verona Pharma submitted its New Drug Application to the U.S. FDA, seeking approval of ensifentrine as a maintenance therapy. In its latest podcast, Optimum Strategic Communications caught up with Chris Martin, Senior Vice President of Commercial, who discussed how the company plans to launch this potential novel COPD medicine.

Hosted on Acast. See acast.com/privacy for more information.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Resolution Therapeutics: pioneering macrophage therapies for liver diseases

2024-08-0827:55

Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader

2024-07-2521:42

How AI is revolutionising drug research

2024-05-3023:39

Curve Therapeutics – Addressing challenging drug targets

2024-05-2312:39

Biotech IPOs make a comeback in 2024

2024-05-1620:55

Anglonordic Life Science Conference strikes optimistic note for ‘24

2024-05-0709:12

The challenges of recruitment for clinical trials

2024-04-0424:16

Lytix Biopharma – Innovations in Killing Cancer

2024-03-0717:07

Tackling Rare Diseases in 2024

2024-02-2938:09

International Day of Women & Girls in Science: Breaking barriers and channeling your inner cavewoman

2024-02-0827:40

Optimum's European Life Sciences Investor Survey 2024

2024-01-2317:46

Vicore Pharma: Restoring lung function for IPF patients

2023-12-1211:29

Optimum's Christmas charity special featuring Ariana Smiles

2023-12-0616:28

4SC: Creating a new treatment paradigm for CTCL

2023-11-2117:30

Episode 10: Optimum's 15th Annual Healthcare Investor Conference Special

2023-11-0208:45

Ask Eva: biopharma's market trends in 2023

2023-09-0714:09

Alchemab: The UK biotech that is revolutionising drug discovery

2023-08-2217:53

Poolbeg Pharma: Using AI to prepare for the next pandemic

2023-08-0816:27

Verona Pharma: Preparing a potentially novel COPD medicine for market

2023-07-2417:32

Søren Møller of Novo Holdings Seed Investments – Helping small biotechs weather the storm

2023-06-2621:28

00:00

Verona Pharma: Preparing a potentially novel COPD medicine for market

#box-pro-ellipsis-17257638671447{-webkit-line-clamp:2;}Verona Pharma: Preparing a potentially novel COPD medicine for market

Verona Pharma: Preparing a potentially novel COPD medicine for market

Verona Pharma: Preparing a potentially novel COPD medicine for market